share_log

Stifel Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16

Benzinga ·  Nov 7, 2023 10:10

Stifel analyst Stephen Manaker maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raises the price target from $14 to $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment